The Latest on Oura’s IPO Postponement: What You Need to Know

After a recent announcement, Oura has decided to delay the sale of a stake in their business on the US stock market, potentially valuing the company at $15 billion. The maker of a smart ring designed to track the health of its users cited uncertainty in the IPO market as the reason for the postponement.

Just over a week ago, CEO Tom Hale outlined plans to raise up to $2.2 billion through offering investors a stake in the company. However, with the current challenges in the IPO market, Oura joins other companies in delaying their listings.

Experts point to various factors contributing to the difficulty in the IPO market, including rising energy costs, global conflicts, trade tensions, and inflation concerns that are impacting central banks and interest rates.

Despite the setback, Oura remains optimistic about the future. “The IPO is just a step in our journey, and we have the flexibility to choose the right timing,” stated Tom Hale.

For the fiscal year ending September 30, 2025, Oura reported pre-tax profits of $23.5 million on sales of $907.8 million, a significant increase from the previous year’s profits. The latest figures show a pre-tax profit of $70 million on sales of $1.2 billion for the nine months ending June 30 this year.

Founded in Finland in 2013 and headquartered in San Francisco, Oura specializes in smart rings priced above $300 that track heart rate, sleep patterns, and more through a dedicated app. The company has faced a class-action lawsuit alleging false advertising related to the accuracy of its sleep tracking capabilities.

Despite the legal challenges, Oura stands by its technology, stating that the ring utilizes various physiological signals to estimate sleep stages accurately.

The decision to postpone the IPO is not related to the lawsuit, according to an Oura spokesperson. “We are committed to our scientific approach and accuracy in our products,” the statement read.